Safety of coadministration of ezetimibe and statins in patients with hypercholesterolaemia: a meta‐analysis
Hypercholesterolaemia is a pivotal risk factor for cardiovascular and cerebrovascular disease and is treated with many effective lipid‐lowering agents. Statins are often used alone or in combination with ezetimibe. Combination therapy is more effective because of its complementary approach, which has major benefits for patients with unmanageable lipid levels. Extensive application of combination therapy has resulted in an increased incidence of side‐effects, which has raised our concern.
No Supplementary Data
No Article Media